ID DEFM_HUMAN Reviewed; 243 AA. AC Q9HBH1; Q8WUN6; DT 05-DEC-2001, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2001, sequence version 1. DT 27-MAR-2024, entry version 173. DE RecName: Full=Peptide deformylase, mitochondrial {ECO:0000303|PubMed:19236878}; DE EC=3.5.1.88 {ECO:0000269|PubMed:19236878}; DE AltName: Full=Polypeptide deformylase; DE Flags: Precursor; GN Name=PDF {ECO:0000303|PubMed:19236878}; GN Synonyms=PDF1A {ECO:0000303|PubMed:11060042}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=11060042; DOI=10.1093/emboj/19.21.5916; RA Giglione C., Serero A., Pierre M., Boisson B., Meinnel T.; RT "Identification of eukaryotic peptide deformylases reveals universality of RT N-terminal protein processing mechanisms."; RL EMBO J. 19:5916-5929(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Lonetto M.A., Zhu Y., Li X., Southan C.; RT "A human homolog of bacterial peptide deformylases."; RL Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-11. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND RP TRANSIT PEPTIDE CLEAVAGE SITE. RX PubMed=14532271; DOI=10.1074/jbc.m309770200; RA Serero A., Giglione C., Sardini A., Martinez-Sanz J., Meinnel T.; RT "An unusual peptide deformylase features in the human mitochondrial N- RT terminal methionine excision pathway."; RL J. Biol. Chem. 278:52953-52963(2003). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION. RX PubMed=15489958; DOI=10.1172/jci22269; RA Lee M.D., She Y., Soskis M.J., Borella C.P., Gardner J.R., Hayes P.A., RA Dy B.M., Heaney M.L., Philips M.R., Bornmann W.G., Sirotnak F.M., RA Scheinberg D.A.; RT "Human mitochondrial peptide deformylase, a new anticancer target of RT actinonin-based antibiotics."; RL J. Clin. Invest. 114:1107-1116(2004). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D., RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). RN [7] RP X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 64-243 IN COMPLEX WITH SUBSTRATE RP ANALOG AND COBALT ION, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, RP METAL-BINDING SITES, SUBSTRATE-BINDING SITES, AND SUBUNIT. RX PubMed=19236878; DOI=10.1016/j.jmb.2009.02.032; RA Escobar-Alvarez S., Goldgur Y., Yang G., Ouerfelli O., Li Y., RA Scheinberg D.A.; RT "Structure and activity of human mitochondrial peptide deformylase, a novel RT cancer target."; RL J. Mol. Biol. 387:1211-1228(2009). CC -!- FUNCTION: Removes the formyl group from the N-terminal Met of newly CC synthesized proteins. {ECO:0000269|PubMed:14532271, CC ECO:0000269|PubMed:15489958, ECO:0000269|PubMed:19236878}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + N-terminal N-formyl-L-methionyl-[peptide] = formate + N- CC terminal L-methionyl-[peptide]; Xref=Rhea:RHEA:24420, Rhea:RHEA- CC COMP:10639, Rhea:RHEA-COMP:10640, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15740, ChEBI:CHEBI:49298, ChEBI:CHEBI:64731; EC=3.5.1.88; CC Evidence={ECO:0000269|PubMed:14532271, ECO:0000269|PubMed:15489958, CC ECO:0000269|PubMed:19236878}; CC -!- COFACTOR: CC Name=Co(2+); Xref=ChEBI:CHEBI:48828; CC Evidence={ECO:0000305|PubMed:19236878}; CC Note=Binds 1 Co(2+) ion. {ECO:0000305|PubMed:19236878}; CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19236878}. CC -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:14532271, CC ECO:0000269|PubMed:15489958}. CC -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:14532271}. CC -!- SIMILARITY: Belongs to the polypeptide deformylase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF239156; AAG33968.1; -; mRNA. DR EMBL; AF322879; AAK15624.1; -; mRNA. DR EMBL; BC019912; AAH19912.1; -; mRNA. DR CCDS; CCDS10875.1; -. DR RefSeq; NP_071736.1; NM_022341.1. DR PDB; 3G5K; X-ray; 1.70 A; A/B/C/D=64-243. DR PDB; 3G5P; X-ray; 1.70 A; A/B/C/D=64-243. DR PDBsum; 3G5K; -. DR PDBsum; 3G5P; -. DR AlphaFoldDB; Q9HBH1; -. DR SMR; Q9HBH1; -. DR BioGRID; 122085; 112. DR IntAct; Q9HBH1; 47. DR STRING; 9606.ENSP00000288022; -. DR BindingDB; Q9HBH1; -. DR ChEMBL; CHEMBL4647; -. DR DrugBank; DB04310; 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide. DR DrugBank; DB04368; Bb-3497. DR SwissPalm; Q9HBH1; -. DR BioMuta; PDF; -. DR DMDM; 17433054; -. DR EPD; Q9HBH1; -. DR jPOST; Q9HBH1; -. DR MassIVE; Q9HBH1; -. DR MaxQB; Q9HBH1; -. DR PaxDb; 9606-ENSP00000288022; -. DR PeptideAtlas; Q9HBH1; -. DR ProteomicsDB; 81550; -. DR Pumba; Q9HBH1; -. DR Antibodypedia; 56384; 197 antibodies from 22 providers. DR DNASU; 64146; -. DR Ensembl; ENST00000288022.2; ENSP00000288022.1; ENSG00000258429.2. DR GeneID; 64146; -. DR KEGG; hsa:64146; -. DR MANE-Select; ENST00000288022.2; ENSP00000288022.1; NM_022341.2; NP_071736.1. DR UCSC; uc002ewx.1; human. DR AGR; HGNC:30012; -. DR CTD; 64146; -. DR DisGeNET; 64146; -. DR GeneCards; PDF; -. DR HGNC; HGNC:30012; PDF. DR HPA; ENSG00000258429; Tissue enhanced (liver). DR MIM; 618720; gene. DR neXtProt; NX_Q9HBH1; -. DR OpenTargets; ENSG00000258429; -. DR PharmGKB; PA144596394; -. DR VEuPathDB; HostDB:ENSG00000258429; -. DR eggNOG; KOG3137; Eukaryota. DR GeneTree; ENSGT00390000018698; -. DR HOGENOM; CLU_061901_5_1_1; -. DR InParanoid; Q9HBH1; -. DR OMA; ILYPMRI; -. DR OrthoDB; 1442148at2759; -. DR PhylomeDB; Q9HBH1; -. DR TreeFam; TF323637; -. DR BRENDA; 3.5.1.88; 2681. DR PathwayCommons; Q9HBH1; -. DR SABIO-RK; Q9HBH1; -. DR SignaLink; Q9HBH1; -. DR BioGRID-ORCS; 64146; 12 hits in 1153 CRISPR screens. DR EvolutionaryTrace; Q9HBH1; -. DR GeneWiki; PDF_(gene); -. DR GenomeRNAi; 64146; -. DR Pharos; Q9HBH1; Tchem. DR PRO; PR:Q9HBH1; -. DR Proteomes; UP000005640; Chromosome 16. DR RNAct; Q9HBH1; Protein. DR Bgee; ENSG00000258429; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 97 other cell types or tissues. DR ExpressionAtlas; Q9HBH1; baseline and differential. DR GO; GO:0005739; C:mitochondrion; IDA:HGNC-UCL. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0042586; F:peptide deformylase activity; IDA:UniProtKB. DR GO; GO:0043686; P:co-translational protein modification; IBA:GO_Central. DR GO; GO:0031365; P:N-terminal protein amino acid modification; IDA:HGNC-UCL. DR GO; GO:0018206; P:peptidyl-methionine modification; IDA:UniProtKB. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:HGNC-UCL. DR GO; GO:0006412; P:translation; IEA:UniProtKB-KW. DR CDD; cd00487; Pep_deformylase; 1. DR Gene3D; 3.90.45.10; Peptide deformylase; 1. DR HAMAP; MF_00163; Pep_deformylase; 1. DR InterPro; IPR023635; Peptide_deformylase. DR InterPro; IPR036821; Peptide_deformylase_sf. DR PANTHER; PTHR10458; PEPTIDE DEFORMYLASE; 1. DR PANTHER; PTHR10458:SF2; PEPTIDE DEFORMYLASE, MITOCHONDRIAL; 1. DR Pfam; PF01327; Pep_deformylase; 1. DR PRINTS; PR01576; PDEFORMYLASE. DR SUPFAM; SSF56420; Peptide deformylase; 1. DR Genevisible; Q9HBH1; HS. PE 1: Evidence at protein level; KW 3D-structure; Cobalt; Hydrolase; Metal-binding; Mitochondrion; KW Protein biosynthesis; Reference proteome; Transit peptide. FT TRANSIT 1..39 FT /note="Mitochondrion" FT /evidence="ECO:0000305|PubMed:14532271" FT CHAIN 40..243 FT /note="Peptide deformylase, mitochondrial" FT /id="PRO_0000006729" FT REGION 165..175 FT /note="Hydrophobic dimerization interface" FT /evidence="ECO:0000269|PubMed:19236878" FT ACT_SITE 215 FT /evidence="ECO:0000250|UniProtKB:P0A6K3" FT BINDING 71 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:19236878" FT BINDING 169 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:19236878" FT BINDING 171 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:19236878" FT BINDING 172 FT /ligand="Co(2+)" FT /ligand_id="ChEBI:CHEBI:48828" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:19236878" FT BINDING 214 FT /ligand="Co(2+)" FT /ligand_id="ChEBI:CHEBI:48828" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:19236878" FT BINDING 218 FT /ligand="Co(2+)" FT /ligand_id="ChEBI:CHEBI:48828" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:19236878" FT VARIANT 11 FT /note="W -> R (in dbSNP:rs8057004)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_060122" FT HELIX 73..75 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 84..86 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 90..105 FT /evidence="ECO:0007829|PDB:3G5K" FT STRAND 109..112 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 113..116 FT /evidence="ECO:0007829|PDB:3G5K" FT STRAND 120..127 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 129..133 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 137..143 FT /evidence="ECO:0007829|PDB:3G5K" FT STRAND 148..170 FT /evidence="ECO:0007829|PDB:3G5K" FT STRAND 178..193 FT /evidence="ECO:0007829|PDB:3G5K" FT STRAND 199..205 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 206..219 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 224..226 FT /evidence="ECO:0007829|PDB:3G5K" FT HELIX 230..232 FT /evidence="ECO:0007829|PDB:3G5K" SQ SEQUENCE 243 AA; 27013 MW; B15A3456F0F8D689 CRC64; MARLWGALSL WPLWAAVPWG GAAAVGVRAC SSTAAPDGVE GPALRRSYWR HLRRLVLGPP EPPFSHVCQV GDPVLRGVAA PVERAQLGGP ELQRLTQRLV QVMRRRRCVG LSAPQLGVPR QVLALELPEA LCRECPPRQR ALRQMEPFPL RVFVNPSLRV LDSRLVTFPE GCESVAGFLA CVPRFQAVQI SGLDPNGEQV VWQASGWAAR IIQHEMDHLQ GCLFIDKMDS RTFTNVYWMK VND //